Features/News

VAP Cholesterol Test Helps
Researchers Identify Treatment
Effects of Combination Therapy
LEARN MORE

Sign up for a Web Seminar on Advanced Lipid Testing.
LEARN MORE


THE VAP TEST
TREATMENT GUIDE
CASE HISTORIES
CLINICAL UPDATES
LITERATURE &
PUBLICATIONS

WELLNESS PARTNERS
HOMOCYSTEINE
& CRP TESTS

EVENTS
NEWS
CME / EDUCATION
LICENSES &
ACCREDITATIONS

CME / Education

VAP Web Seminars
 

The following Web Seminars are scheduled to educate and inform healthcare clinicians about different topics of advanced lipid testing. Please note the following seminars are not CME.

November 14    General overview of the VAP cholesterol test. – How the results determine risk and aid in therapeutic selection.

December 5    DIACOR – The effects of combination versus monotherapy in diabetic patients. Implications in lipid management and future trends.

January 9    Utilizing the VAP cholesterol test to identify patients at increased risk despite normal cholesterol results – an IVUS substudy of the Diabetes Genome Project (DGP).

February 6    New current consensus guidelines for the utilization of LDL cholesterol, nonHDL cholesterol, and apolipoprotein B100 (apoB) – What does this mean for healthcare?
 

All seminars will be scheduled for 1pm and 3pm EST
 

Fill out this form if you would like to register for a Web Seminar.
 

First Name:
Last Name:
City:
State:
Email Address:
Phone:
 
Seminar you would like to attend:
 

November 14    General overview of the VAP cholesterol test. – How the results determine risk and aid in therapeutic selection.

    1pm EST

    3pm EST

December 5    DIACOR – The effects of combination versus monotherapy in diabetic patients. Implications in lipid management and future trends.

    1pm EST

    3pm EST

January 9    Utilizing the VAP cholesterol test to identify patients at increased risk despite normal cholesterol results – an IVUS substudy of the Diabetes Genome Project (DGP).

    1pm EST

    3pm EST

February 6    New current consensus guidelines for the utilization of LDL cholesterol, nonHDL cholesterol, and apolipoprotein B100 (apoB) – What does this mean for healthcare?

    1pm EST

    3pm EST
 


 

Atherotech’s Chief Medical Officer, Dr. Jim Ehrlich, will be faculty on the Breakthroughs in Preventive Medicine Cruise Conference. http://www.continuingeducation.net/coursedetails.php?program_number=646

Interested in CME?

If so, please Contact Us to learn more about the educational opportunities provided by Atherotech.


Home | Contact Us | Privacy Policy |  © 2009 Atherotech